Research Use Only
Cabergoline 0.25mg (30 Tablets)
Laboratory-grade tablets • Not for human or veterinary use
Cabergoline is a research compound classified as a dopamine D2 receptor agonist.
It is commonly explored in laboratory settings for its potential impact on prolactin regulation,
pituitary signaling, and dopamine-mediated pathways.
Key Research Points
- Dopamine D2 receptor agonist
- Investigated for prolactin suppression in controlled research
- Useful in studies of neuroendocrine and pituitary pathways
- Extended half-life suitable for infrequent, protocol-based sampling
Form
Oral Tablets
Strength
0.25mg per tablet
Quantity
30 tablets
Storage
Cool, dry place < 25°C
Disclaimer: For laboratory research use only. Not approved for human or veterinary use, ingestion, or medical applications.
Handle using appropriate laboratory PPE and protocols.
Handle using appropriate laboratory PPE and protocols.
